Andrew J. Armanino, Director at Better Therapeutics, Inc. (BTTX), bought 548,020 shares at $0.73 ($400K) on 2023-07-27, disclosed to the SEC on 2023-07-31.
Open-market purchase of $400k BTTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.73 | 274,010 | $200K | 50.0% |
| 2 | $0.73 | 274,010 | $200K | 50.0% |
| Total | $0.73 avg | 548,020 | $400K | 100% |
| Filing → |
| BTTX | BUY | 2022-06-16 | $21K | — | Filing → |
| BTTX | BUY | 2022-06-10 | $41K | — | Filing → |
| BTTX | BUY | 2022-03-31 | $86K | — | Filing → |